MENU
+Compare
ECOR
Stock ticker: NASDAQ
AS OF
Dec 18, 12:27 PM (EDT)
Price
$16.63
Change
+$2.70 (+19.38%)
Capitalization
37.04M

ECOR electroCore Forecast, Technical & Fundamental Analysis

a developer of non-invasive neuromodulation therapies

ECOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ECOR with price predictions
Dec 17, 2024

ECOR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ECOR turned positive on December 09, 2024. Looking at past instances where ECOR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 02, 2024. You may want to consider a long position or call options on ECOR as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ECOR advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where ECOR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ECOR moved out of overbought territory on December 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECOR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ECOR broke above its upper Bollinger Band on December 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ECOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.936) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.106) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
ECOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of non-invasive neuromodulation therapies

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
200 Forge Way
Phone
+1 973 290-0097
Employees
61
Web
https://www.electrocore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXPO93.780.72
+0.77%
Exponent
CWH21.76-0.02
-0.09%
Camping World Holdings
LYG2.73-0.04
-1.44%
Lloyds Banking Group PLC
CZNC19.33-0.42
-2.13%
Citizens & Northern Corp
DTIL4.58-0.16
-3.38%
Precision BioSciences

ECOR and Stocks

Correlation & Price change

A.I.dvisor tells us that ECOR and CORBF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
-2.45%
CORBF - ECOR
27%
Poorly correlated
N/A
ILMN - ECOR
24%
Poorly correlated
-0.89%
INMD - ECOR
24%
Poorly correlated
-0.78%
NVCR - ECOR
24%
Poorly correlated
+1.09%
UEEC - ECOR
23%
Poorly correlated
+0.08%
More